Search Results

Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical

More than a technical overview, this is a story of curiosity, persistence, and using science to meet Rather than being discouraged by challenges, he views them as forcing functions for creativity and growth

This time with none other than Dr. Bryan Roth There are 10 open tickets available. Get yours now!

The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility

Here, the Schild plot becomes a diagnostic tool  rather than a checkbox test: Slopes >1  often mean incomplete to Partial Agonists Partial agonists complicate things—they activate receptors but less effectively than

GPCR Podcast, we have none other than Dr. Marta Filizola!

grows, it becomes a searchable extension of Terry’s teaching — designed for repeated exposure rather than

Our guest is none other than Dr. Juan Jose Fung, Principal Scientist, at GPCR Therapeutics.

Our first guest speaker is none other than Dr. Ben Myers!

determine partner preference; or (iii) the dynamics of GPCR binding to different types of partners rather than

Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous

is quite stable, the number of ORs expressed in different human tissues is highly variable from more than For example, OR4M1 was proposed to interfere with aberrant tau hyperphosphorylation (Zhao W. et. al 2013

in academia or biotech, the future belongs to research groups that can orchestrate ecosystems rather than He treats modeling as part of a continuum rather than a separate discipline.

One potential solution is to develop analgesics that act at targets other than opioid receptors.

Hassard is a commercial leader with more than three decades of experience leading sales and marketing

A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-Gi

Unlocking the Secrets of Orthosteric Binding Understanding why some drugs bind better than others is

This is more than review, it’s readiness.

In less than a decade, nanobodies, or recombinant single-domain antibody fragments from camelids, have

A GPCR Internalization Tool Designed for Real Research Needs Built on more than two decade A GPCR Internalization

Clues that point to true multiple-site binding rather than two-stage GPCR biology: Disrupting G protein If the tracer binds faster than the displacer, early time points exaggerate tracer occupancy and underestimate

Rather than focusing solely on explaining receptor behavior post hoc, his group began developing workflows Carlsson notes that it’s easier to find pharmacologists to run assays than it is to persuade chemists

and anxiety, has shown, in the last decade, increasing evidence of its antitumoral properties in more than

intermediate state complex comprising β1-AR and nucleotide-free Gs is more stable when binding a full agonist than

In fact, it is often costly, frustrating, and tortuous—and more often than not it ends in failure.

Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. Zhang, and L. Ma. 2008.

Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences

Six compounds showed more than 50% displacement of the radioligand at 10 µM concentration with compound

He has led teams that have filed more than 10 Investigational New Drug Applications (IND), as well as

However, our predictions were many folds shorter than those determined experimentally.